TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 66 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,964,641 | -42.5% | 788,115 | +0.1% | 0.00% | -100.0% |
| Q2 2023 | $6,890,721 | +91.0% | 787,511 | +158.4% | 0.00% | – |
| Q1 2023 | $3,607,837 | +199448.5% | 304,716 | +71.5% | 0.00% | – |
| Q4 2022 | $1,808 | -99.8% | 177,648 | +5.2% | 0.00% | – |
| Q3 2022 | $994,000 | +407.1% | 168,848 | +112.9% | 0.00% | – |
| Q2 2022 | $196,000 | -63.2% | 79,324 | -55.8% | 0.00% | – |
| Q1 2022 | $532,000 | -58.4% | 179,311 | -0.9% | 0.00% | – |
| Q4 2021 | $1,279,000 | -36.5% | 180,935 | -6.4% | 0.00% | – |
| Q3 2021 | $2,014,000 | +14.8% | 193,336 | +35.1% | 0.00% | – |
| Q2 2021 | $1,754,000 | -38.8% | 143,069 | +9.8% | 0.00% | – |
| Q1 2021 | $2,865,000 | – | 130,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |